Comparing the New Anti-cancer Drug Eribulin With or Without Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Bladder Cancer
Conditions: Metastatic Bladder Urothelial Carcinoma; Refractory Bladder Urothelial Carcinoma; Stage IV Bladder Cancer AJCC v8; Stage IVA Bladder Cancer AJCC v8; Stage IVB Bladder Cancer AJCC v8 Interventions: Drug: Docetaxel; Drug: Eribulin Mesylate; Drug: Gemcitabine Hydrochloride; Drug: Paclitaxel Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Docetaxel | Research | Taxotere